Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003410 · ClinicalTrials.gov registry record · Phase 1
Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
A Phase 1 study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00003410 is a Phase 1 study that has completed, run by Jonsson Comprehensive Cancer Center.
The verdict
NCT00003410, a Phase 1 study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma.
Interventions
- DRUG motexafin gadolinium
- PROCEDURE magnetic resonance imaging
- PROCEDURE surgical procedure
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-07 |
| Est. Completion | 2004-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003410
The ClinicalTrials.gov registry entry for NCT00003410 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which motexafin gadolinium is the first listed.
NCT00003410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003410 about?
NCT00003410 is a clinical study titled "Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas". RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma.
What is the current status of trial NCT00003410?
This trial is currently completed. It is a Phase 1 study. The study started on 1998-07. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00003410?
The interventions under investigation include: motexafin gadolinium (DRUG), magnetic resonance imaging (PROCEDURE), surgical procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00003410?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.